After the success of a new drug treatment in adults with hepatitis C infection, a Saint Louis University pediatric researcher is testing the safety and efficacy of the medications in children. Part of a multi-center clinical study, SLU is the only center in the region that will examine a combination of two drugs – Sofosbuvir and Ribavirin – in children between ages 3 and 17. The aim of the study is to cure the infection with few side effects.
The current approach to treat the hepatitis C infection is with interferon shots combined with Ribavirin, a therapy that takes about six to 12 months and also causes many side effects including, flu-like symptoms and depression.
“Many times patients would be on the traditional medication but quit within a year. It’s a very difficult treatment, with a cure rate of 50 percent,” says Jeffrey Teckman, MD, professor of pediatrics and principal investigator of the study at SLU. "The new study will consist of all oral medication. That would mean no shots or flu-like side effects, and also much shorter course of treatment."
The medication has shown 90 to 100 percent cure rate in adults and Teckman hopes to see the same results in children. His main aim is to test if the side effects would be as low in children as they were in adults, and to see if children need extra time for the drugs to work.
For this study, the team will test Sofosbuvir, a new drug, and Ribavirin, which is used in the treatment with interferon. Teckman said the new medication could cause lesser side effects, like already seen in adults.
“I think this treatment is a real game changer,” says Teckman, who is also a SLUCare pediatric gastroenterologist at SSM Cardinal Glennon Children’s Medical Center. “The previous treatments were arduous. People would often start the treatment, but eventually drop out. This new therapy is a revolution that affects people around the world.”
Teckman believes, unlike studies for adults, research for children is lagging behind.
“A lot of times studies for children don’t get approved. The exciting part with our study is that the medication has already been tested in adults, and we are moving rapidly to test in children,” he says.
Hepatitis C is a viral disease that leads to inflammation of the liver. The CDC says about 3.2 million people in the United States are affected by the hepatitis C infection, out of which Teckman believes 5 percent are children.
“Hepatitis C takes a long time to damage the body, but eventually it can be fatal. It’s important to cure people,” Teckman says.
Source: Saint Louis University Medical Center
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.